These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 1900882

  • 1. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K, Salmeron MA, Kornbluth J, Bucana C, Itoh K.
    J Immunol; 1991 Apr 01; 146(7):2453-60. PubMed ID: 1900882
    [Abstract] [Full Text] [Related]

  • 2. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J.
    J Immunol; 1993 Mar 01; 150(5):1705-14. PubMed ID: 7679691
    [Abstract] [Full Text] [Related]

  • 3. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1993 Mar 01; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 4. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R, Bockstoce DC, Golub SH.
    Lymphokine Cytokine Res; 1994 Dec 01; 13(6):349-57. PubMed ID: 7535569
    [Abstract] [Full Text] [Related]

  • 7. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G.
    Nat Immun Cell Growth Regul; 1987 Dec 01; 6(4):171-88. PubMed ID: 2960890
    [Abstract] [Full Text] [Related]

  • 8. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Ramírez A, Silva A, Acevedo A, Sánchez-Madrid F, De Landázuri MO, López-Botet M.
    J Immunol; 1990 Apr 15; 144(8):3238-47. PubMed ID: 1691231
    [Abstract] [Full Text] [Related]

  • 9. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A, Bell GI, Director EP.
    J Immunol; 1988 Jul 15; 141(2):690-8. PubMed ID: 3133414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B, Gately M, Espevik T.
    J Immunol; 1992 Apr 15; 148(8):2429-36. PubMed ID: 1373169
    [Abstract] [Full Text] [Related]

  • 12. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 15; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 13. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan 15; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 16. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug 15; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 17. Functional consequences of cAMP accumulation in human natural killer cells. Implications for IL-2 and IL-4 signal transduction.
    Vitté-Mony I, Stancou R, Bertoglio JH.
    J Immunol; 1990 Dec 15; 145(12):4272-8. PubMed ID: 2175326
    [Abstract] [Full Text] [Related]

  • 18. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC, Hsiao MH, Pattengale PK.
    Nat Immun Cell Growth Regul; 1991 Dec 15; 10(2):57-70. PubMed ID: 1881400
    [Abstract] [Full Text] [Related]

  • 19. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
    Nagler A, Lanier LL, Phillips JH.
    J Immunol; 1988 Oct 01; 141(7):2349-51. PubMed ID: 3262658
    [Abstract] [Full Text] [Related]

  • 20. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.